Tamoxifen induces vasorelaxation via inhibition of mitogen-activated protein kinase in rat aortic smooth muscle

Journal of Veterinary Medical Science

Volumn 65, Issue 11, 2003, Pages 1155-1160

  Park, Sohyun ^a   Kim, Bokyung ^b   Kim, Junghwan ^b   Won, Kyung Jong ^a   Lee, Sangmok ^a   Kwon, Seongchun ^c   Cho, Sungil ^a  

^a Konkuk University   (South Korea)

^b Konkuk University   (South Korea)

^c Kwandong University College of Medicine   (South Korea)

Author keywords

Endothelin 1; MAPK; Relaxation; Tamoxifen; Vascular smooth muscle

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; DRUG DERIVATIVE; ENDOTHELIN 1; ESTRADIOL; FULVESTRANT; IMIDAZOLE DERIVATIVE; PYRIDINE DERIVATIVE; TAMOXIFEN;

ANIMAL; AORTA; ARTICLE; COMPARATIVE STUDY; DRUG EFFECT; METABOLISM; PHYSIOLOGY; RAT; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE; VASODILATATION; WESTERN BLOTTING;

ANIMALS; AORTA; BLOTTING, WESTERN; ENDOTHELIN-1; ESTRADIOL; IMIDAZOLES; MAP KINASE SIGNALING SYSTEM; MUSCLE, SMOOTH, VASCULAR; PYRIDINES; RATS; TAMOXIFEN; VASODILATION;

EID: 1542574018     PISSN: 09167250     EISSN: None     Source Type: Journal    
DOI: 10.1292/jvms.65.1155     Document Type: Article

References (35)

1. Adam, L. P. and Hathaway, D. R. 1993. Identification of mitogen-activated protein kinase phosphorylation sequences in mammalian h-Caldesmon. FEBS Lett. 322: 56-60.
2. Anker, G., Lonning, P. E., Ueland, P. M., Refsum, H. and Lien, E. A. 1995. Plasma levels of the atherogenic amino acid homocysteine in post-menopausal women with breast cancer treated with tamoxifen. Int. J. Cancer 60: 365-368.
3. i sensitization pathways. Hypertension 39: 543-549.
4. Dessy, C., Kim, I., Sougnez, C. L., Laporte, R. and Morgan, K. G. 1998. A role for MAP kinase in differentiated smooth muscle contraction evoked by alpha-adrenoceptor stimulation. Am. J. Physiol. 275: C1081-C1086.
5. Dubey, R. K., Jackson, E. K., Gillespie, D. G., Zacharia, L. C., Imthurn, B. and Keller, P. J. 2000. Clinically used estrogens differentially inhibit human aortic smooth muscle cell growth and mitogen-activated protein kinase activity. Arterioscler. Thromb. Vasc. Biol. 20: 964-972.
6. Figtree, G. A., Webb, C. M. and Collins, P. 2000. Tamoxifen acutely relaxes coronary arteries by an endothelium-, nitric oxide-, and estrogen receptor-dependent mechanism. J. Pharmacol. Exp. Ther. 295: 519-523.
7. Gerthoffer, W. T., Yamboliev, I. A., Pohl, J., Haynes, R., Dang, S. and McHugh, J. 1997. Activation of MAP kinases in airway smooth muscle. Am. J. Physiol. 272: L244-L252.
8. Hedges, J. C., Oxhorn, B. C., Carty, M., Adam, L. P., Yamboliev, I. A. and Gerthoffer, W. T. 2000. Phosphorylation of caldesmon by ERK MAP kinases in smooth muscle. Am. J. Physiol. 278: C718-C726.
9. Husain, S. and Abdel-Latif, A. A. 1999. Endothelin-1 activates p38 mitogen-activated protein kinase and cytosolic phospholipase A2 in cat iris sphincter smooth muscle cells. Biochem. J. 342: 87-96.
10. Hwang, K. C., Lee, K. H. and Jang, Y. 2002. Inhibition of MEK1,2/ERK mitogenic pathway by estrogen with antiproliferative properties in rat aortic smooth muscle cells. J. Steroid Biochem. Mol. Biol. 80: 85-90.
11. Ishihata, A., Tasaki, K. and Katano, Y. 2002. Involvement of p44/42 mitogen-activated protein kinases in regulating angiotensin II- and endothelin-1-induced contraction of rat thoracic aorta. Eur. J. Pharmacol. 445: 247-256.
12. Kamm, K. E. and Stull, J. T. 1985. The function of myosin and myosin light chain kinase phosphorylation in smooth muscle. Annu. Rev. Pharmacol. Toxicol. 25: 593-620.
13. Karaki, H., Ozaki, H., Hori, M., Mitsui-Saito, M., Amano, K., Harada, K., Miyamoto, S., Nakazawa, H., Won, K. J. and Sato, K. 1997. Calcium movements, distribution, and functions in smooth muscle. Pharmacol. Rev. 49: 157-230.
14. Katoch, S. S. and Moreland, R. S. 1995. Agonist and membrane depolarization induced activation of MAP kinase in the swine carotid artery. Am. J. Physiol. 269: H222-H229.
15. 2+ influx and endothelin-1-induced intracellular mitogenic cascades in rabbit internal carotid artery vascular smooth muscle cells. J. Cardiovasc. Pharmacol. 40: 307-314.
16. Khalil, R. A. and Morgan, K. G. 1993. PKC-mediated redistribution of mitogen-activated protein kinase during smooth muscle cell activation. Am. J. Physiol. 265: C406-C411.
17. 2+ and contraction in vascular smooth muscle. Eur. J. Pharmacol. 223: 157-162.
18. Kubo, T., Ibusuki, T., Saito, E., Kambe, T. and Hagiwara, Y. 2000. Different activation of vascular mitogen-activated protein kinases in spontaneously and DOCA-salt hypertensive rats. Eur. J. Pharmacol. 400: 231-237.
19. Kwon, S., Lee, W. J., Fang, L. H., Kim, B. and Ahn, H. Y. 2003. Mitogen-activated protein kinases partially regulate endothelin-1-induced contractions through a myosin light chain phosphorylation-independent pathway. J. Vet. Med. Sci. 65: 225-230.
20. Lipton, A. 1987. The anti-oestrogen tamoxifen is a calcium antagonist in perfused rat mesentery. Cancer Chemother. Pharmacol. 20: 125-127.
21. Love, R. R., Barden, H. S., Mazess, R. B., Epstein, S. and Chappell, R. J. 1994. Effect of tamoxifen on lumbar spine bone mineral density in postmenopausal women after 5 years. Arch. Intern. Med. 154: 2585-2588.
22. Miyata, Y. and Nishida, E. 1999. Distantly related cousins of MAP kinase: biochemical properties and possible physiological functions. Biochem. Biophys. Res. Commun. 266: 291-295.
23. Morey, A. K., Pedram, A., Razandi, M., Prins, B. A., Hu, R. M., Biesiada, E. and Levin, E. R. 1997. Estrogen and progesterone inhibit vascular smooth muscle proliferation. Endocrinology 138: 3330-3339.
24. Ohanian, J., Cunliffe, P., Ceppi, E., Alder, A., Heerkens, E. and Ohanian, V. 2001. Activation of p38 mitogen-activated protein kinases by endothelin and noradrenaline in small arteries, regulation by calcium influx and tyrosine kinases, and their role in contraction. Arterioscler. Thromb. Vasc. Biol. 21: 1921-1927.
25. Ratz, P. H., McCammon, K. A., Altstatt, D., Blackmore, P. F., Shenfeld, O. Z. and Schlossberg, S. M. 1999. Differential effects of sex hormones and phytoestrogens on peak and steady state contractions in isolated rabbit detrusor. J. Urol. 162: 1821-1828.
26. Saarto, T., Blomqvist, C., Ehnholm, C., Taskinen, M. R. and Elomaa, I. 1996. Antiatherogenic effects of adjuvant antiestrogens: a randomized trial comparing the effects of tamoxifen and toremifene on plasma lipid levels in postmenopausal women with node-positive breast cancer. J. Clin. Oncol. 14: 429-433.
27. 2+ entry inhibition. J. Cereb. Blood Flow Metab. 21: 422-429.
28. Song, J., Standley, P. R., Zhang, F., Joshi, D., Gappy, S., Sowers, J. R. and Ram, J. L. 1996. Tamoxifen (estrogen antagonist) inhibits voltage-gated calcium current and contractility in vascular smooth muscle from rats. J. Pharmacol. Exp. Ther. 277: 1444-1453.
29. Touyz, R. M., El Mabrouk, M., He, G., Wu, X. H. and Schiffrin, E. L. 1999. Mitogen-activated protein/extracellular signal-regulated kinase inhibition attenuates angiotensin II-mediated signaling and contraction in spontaneously hypertensive rat vascular smooth muscle cells. Circ. Res. 84: 505-515.
30. Watts, S. W. 1996. Serotonin activates the mitogen-activated protein kinase pathway in vascular smooth muscle: use of the mitogen-activated protein kinase inhibitor PD098059. J. Pharmacol. Exp. Ther. 279: 1541-1550.
31. Widmann, C., Gibson, S., Jarpe, M. B. and Johnson, G. L. 1999. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol. Rev. 79: 143-180.
32. Wiseman, H. 1995. Tamoxifen as an antioxidant and cardioprotectant. Biochem. Soc. Symp. 61: 209-219.
33. Yamboliev, I. A., Hruby, A. and Gerthoffer, W. T. 1998. Endothelin-1 activates MAP kinases and c-Jun in pulmonary artery smooth muscle. Pulm. Pharmacol. Ther. 11: 205-208.
34. Yamboliev, I. A., Hedges, J. C., Mutnick, J. L., Adam, L. P. and Gerthoffer, W. T. 2000. Evidence for modulation of smooth muscle force by the p38 MAP kinase/HSP27 pathway. Am. J. Physiol. 278: H1899-H1907.
35. Zhang, L., Li, B., Zhao, W., Chang, Y. H., Ma, W., Dragan, M., Barker, J. L., Hu, Q. and Rubinow, D. R.2002. Sex-related differences in MAPKs activation in rat astrocytes: effects of estrogen on cell death. Mol. Brain Res. 103: 1-11.